Amplia Therapeutics Ltd banner

Amplia Therapeutics Ltd
OTC:INNMF

Watchlist Manager
Amplia Therapeutics Ltd Logo
Amplia Therapeutics Ltd
OTC:INNMF
Watchlist
Price: 0.097 USD Market Closed
Market Cap: $26.3m

Wall St Price Targets

INNMF Price Targets Summary
Amplia Therapeutics Ltd

Wall Street analysts forecast INNMF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INNMF is 0.308 USD with a low forecast of 0.305 USD and a high forecast of 0.317 USD.

Lowest Forecast
Price Target
0.305 USD
214% Upside
Average Forecast
Price Target
0.308 USD
217% Upside
Highest Forecast
Price Target
0.317 USD
227% Upside
Amplia Therapeutics Ltd Competitors:
Price Targets
EBMT
Eagle Bancorp Montana Inc
2% Upside
PGEN
Precigen Inc
120% Upside
NCSM
NCS Multistage Holdings Inc
59% Upside

Revenue
Forecast

25% / Year
Past Growth
39% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
25% / Year
Past Growth
39% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 39%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is INNMF's stock price target?
Price Target
0.308 USD

According to Wall Street analysts, the average 1-year price target for INNMF is 0.308 USD with a low forecast of 0.305 USD and a high forecast of 0.317 USD.

What is the Revenue forecast for Amplia Therapeutics Ltd?
Projected CAGR
39%

Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 39%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett